Trademark Details For HEMATACHEK (Serial Number 76114313)

  •  Home
  •  Print
HEMATACHEK
1
7
4
0
Serial Number  United States - USPTO 76114313
Registration Number 2479977
Mark
HEMATACHEK
Filing Date Aug-22-2000
Status
Registered  
REGISTERED A.. (800)
REGISTERED AND RENEWED
Attorney Name
TTAB
0



  • Mark Literal Elements:

009Electrical and scientific apparatus

U.S Class(es): 021, 023, 026, 036, 038

Class Status: Active

First Use: Mar-14-1990

First Use in Commerce: Mar-1990





Correspondences

NameMichael D. Fishman
AddressFishman Stewart PLLC 800 Tower Drive, Suite 610 Troy MI 48098

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Feb-06-2001ASSIGNED TO EXAMINER   DOCKD
Feb-26-2001EXAMINER'S AMENDMENT MAILED   CNEAF
Mar-04-2001APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
May-16-2001NOTICE OF PUBLICATION   NPUBO
May-29-2001PUBLISHED FOR OPPOSITION   PUBOA
Aug-21-2001REGISTERED-PRINCIPAL REGISTER   R.PRA
Jan-08-2004TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Jan-26-2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
Jan-26-2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
Feb-02-2007TEAS SECTION 8 & 15 RECEIVED   E815I
Feb-02-2007REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED   815FI
Feb-16-2007CASE FILE IN TICRS   CFITO
Mar-14-2007ASSIGNED TO PARALEGAL   PLGLA
Mar-31-2007REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Jul-20-2011TEAS SECTION 8 & 9 RECEIVED   E89RI
Jul-22-2011REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Jul-22-2011REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)   RNL1Q
Aug-21-2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED   REM2E
Aug-06-2021TEAS SECTION 8 & 9 RECEIVED   E89RI
Jan-14-2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Jan-14-2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Jan-14-2022REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)   RNL2Q
Jan-14-2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED   NA89E